Analytical Data
-
Gene name
CDHH
- Application
-
Alternative Names
CDHH；CDHH；Cadherin-13
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55290
-
Expression Region
139-693aa
-
AA Sequence
SI VVSPILIPEN QRQPFPRDVG KVVDSDRPER SKFRLTGKGV DQEPKGIFRI NENTGSVSVT RTLDREVIAV YQLFVETTDV NGKTLEGPVP LEVIVIDQND NRPIFREGPY IGHVMEGSPT GTTVMRMTAF DADDPATDNA LLRYNIRQQT PDKPSPNMFY IDPEKGDIVT VVSPALLDRE TLENPKYELI IEAQDMAGLD VGLTGTATAT IMIDDKNDHS PKFTKKEFQA TVEEGAVGVI VNLTVEDKDD PTTGAWRAAY TIINGNPGQS FEIHTNPQTN EGMLSVVKPL DYEISAFHTL LIKVENEDPL VPDVSYGPSS TATVHITVLD VNEGPVFYPD PMMVTRQEDL SVGSVLLTVN ATDPDSLQHQ TIRYSVYKDP AGWLNINPIN GTVDTTAVLD RESPFVDNSV YTALFLAIDS GNPPATGTGT LLITLEDVND NAPFIYPTVA EVCDDAKNLS VVILGASDKD LHPNTDPFKF EIHKQAVPDK VWKISKINNT HALVSLLQNL NKANYNLPIM VTDSGKPPMT NITDLRVQVC SCRNSKVDCN AAG
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on CDHH recombinant protein (Cystathionine β-synthase with a dual function in heme degradation) has emerged from the necessity to understand its role in various biological processes and its potential implications in disease mechanisms. CDHH, a protein of interest due to its involvement in heme metabolism, is crucial for maintaining cellular homeostasis and responding to oxidative stress. Impaired function of CDHH has been linked to several pathologies, including neurodegenerative diseases and certain types of cancers. As a result, scientists are focusing on recombinant forms of CDHH to dissect its functional properties and interactions within cellular environments. These recombinant proteins allow for detailed structural and functional studies, facilitating insights into the enzyme's catalytic mechanisms and its regulatory pathways. Moreover, the ability to produce CDHH in a controlled laboratory setting opens avenues for therapeutic applications, including the development of novel treatments that could mitigate the effects of diseases associated with heme imbalance. Overall, the exploration of CDHH recombinant protein represents a significant stride in biochemical research, potentially leading to innovative strategies in disease management and therapeutic interventions.
